<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2024.1501874</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Post-translational modifications of beta-amyloid modulate its effect on cell mechanical properties and influence cytoskeletal signaling cascades</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Varshavskaya</surname> <given-names>Kseniya B.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2616109/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Barykin</surname> <given-names>Evgeny P.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Timoshenko</surname> <given-names>Roman V.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kolmogorov</surname> <given-names>Vasilii S.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Erofeev</surname> <given-names>Alexander S.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2207690/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Gorelkin</surname> <given-names>Petr V.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Mitkevich</surname> <given-names>Vladimir A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/416494/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Makarov</surname> <given-names>Alexander A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/137313/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Engelhardt Institute of Molecular Biology</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Research Laboratory of Biophysics, National University of Science and Technology &#x201C;MISIS&#x201D;</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Chemistry, Lomonosov Moscow State University</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Rossella Di Giaimo, University of Naples Federico II, Italy</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Domenico Azarnia Tehran, Leibniz-Institut f&#x00FC;r Molekulare Pharmakologie (FMP), Germany</p>
<p>Veronica Maria Pravata, Max Planck Institute of Psychiatry (MPI), Germany</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Vladimir A. Mitkevich, <email>mitkevich@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>11</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>17</volume>
<elocation-id>1501874</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Varshavskaya, Barykin, Timoshenko, Kolmogorov, Erofeev, Gorelkin, Mitkevich and Makarov.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Varshavskaya, Barykin, Timoshenko, Kolmogorov, Erofeev, Gorelkin, Mitkevich and Makarov</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Post-translational modifications of beta-amyloid (A&#x03B2;) play an important role in the pathogenesis of Alzheimer&#x2019;s disease (AD). A&#x03B2; modifications such as Ser8 phosphorylation (pS8-A&#x03B2;<sub>42</sub>) and Asp7 isomerization (iso-A&#x03B2;<sub>42</sub>) can significantly alter the properties of A&#x03B2; and have been detected <italic>in vivo</italic>. One of the reasons for the different pathogenicity of A&#x03B2; isoforms may be the activation of different signaling cascades leading to changes in the mechanical properties of cells. In this paper, we used correlative scanning ion-conductance microscopy (SICM) and Pt-nanoelectrodes to compare the effects of A&#x03B2; isoforms on the Young&#x2019;s modulus of SH-SY5Y cells and the level of ROS. It was found that unmodified A&#x03B2;<sub>42</sub> resulted in the largest increase in cell Young&#x2019;s modulus of all isoforms after 4&#x2009;h of incubation, while pS8-A&#x03B2;<sub>42</sub> induced the greatest increase in stiffness and ROS levels after 24&#x2009;h of incubation. Analysis of signaling proteins involved in the regulation of the actin cytoskeleton showed that A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> have different effects on cofilin, GSK3&#x03B2;, LIMK, ERK and p38. This indicates that post-translational modifications of A&#x03B2; modulate its effect on neuronal cells through the activation of various signaling cascades, which affects the mechanical properties of cells.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer&#x2019;s disease</kwd>
<kwd>beta-amyloid</kwd>
<kwd>post-translational modifications</kwd>
<kwd>scanning ion-conductance microscopy</kwd>
<kwd>ROS</kwd>
<kwd>actin cytoskeleton</kwd>
<kwd>cofilin</kwd>
<kwd>protein kinases</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="2"/>
<ref-count count="62"/>
<page-count count="12"/>
<word-count count="8109"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular Signalling and Pathways</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Alzheimer&#x2019;s disease (AD) is the most common cause of dementia worldwide (<xref ref-type="bibr" rid="ref1">Anand et al., 2014</xref>). One of the hallmarks of AD is the formation of amyloid plaques in various parts of the brain, consisting mainly of beta-amyloid peptide (A&#x03B2;). A&#x03B2; is known to undergo various post-translational modifications that affect its aggregation, toxicity, enzymatic degradation, and interaction with protein partners (<xref ref-type="bibr" rid="ref8">Barykin et al., 2017</xref>). Many studies note that the presence of A&#x03B2;<sub>42</sub> alone is not enough for the development of pathology: the appearance of modified forms that change the action of A&#x03B2;<sub>42</sub> serves as a trigger for the disease (<xref ref-type="bibr" rid="ref8">Barykin et al., 2017</xref>). Some of these modifications include phosphorylation at serine 8 (pS8-A&#x03B2;<sub>42</sub>) and isomerization of aspartic acid 7 (iso-A&#x03B2;<sub>42</sub>). A&#x03B2; containing isomerized Asp7 was found in more than 50% of the A&#x03B2; molecules of amyloid plaques, as well as in soluble fraction (<xref ref-type="bibr" rid="ref43">Mukherjee et al., 2021</xref>). This modification is more prone to aggregation than unmodified A&#x03B2; and has greater toxicity and resistance to degradation by enzymes (<xref ref-type="bibr" rid="ref36">Kummer and Heneka, 2014</xref>; <xref ref-type="bibr" rid="ref20">Gnoth et al., 2020</xref>). Another important modification of A&#x03B2;, phosphorylation of Ser8, influences the neurotoxicity of the peptide and has been found in the brains of AD patients and in the brains of transgenic animals modeling AD (<xref ref-type="bibr" rid="ref36">Kummer and Heneka, 2014</xref>; <xref ref-type="bibr" rid="ref35">Kumar et al., 2018</xref>). We have shown that iso-A&#x03B2;<sub>42</sub> is a more potent inhibitor of &#x03B1;7 nAChR than the unmodified peptide (<xref ref-type="bibr" rid="ref7">Barykin et al., 2019</xref>), and the inhibition of Na<sup>+</sup>/K<sup>+</sup>-ATPase by beta-amyloid is completely eliminated by phosphorylation of the peptide at Ser8 (<xref ref-type="bibr" rid="ref9">Barykin et al., 2018</xref>). Thus, pS8-A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> represent important isoforms whose properties are significantly different from unmodified A&#x03B2;.</p>
<p>The difference in the pathogenicity of beta-amyloid isoforms for neuronal cells may be due to their different effects on the mechanical properties of cells. The mechanical properties of cells are closely related to many important biological functions, such as adhesion, division, motility, differentiation and deformation, and are controlled mainly by the cytoskeleton (<xref ref-type="bibr" rid="ref38">Luo et al., 2016</xref>). A&#x03B2; has been shown to induce changes in the cytoskeleton and mechanical properties of neuronal cells (<xref ref-type="bibr" rid="ref57">Ungureanu et al., 2016</xref>; <xref ref-type="bibr" rid="ref31">Kolmogorov V. S. et al., 2023</xref>), but whether the modified forms have the same properties has not been previously studied. Establishing differences in the properties and effects of beta-amyloid isoforms may be important for a complete study of the mechanism of AD development.</p>
<p>In this study, we measured cell stiffness and ROS production in response to A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub>. Next, we aimed to discover which signaling cascades associated with the regulation of cell mechanical properties through influence on the actin cytoskeleton and ROS are activated by A&#x03B2; and its isoforms. Cofilin, which plays a key role in cytoskeletal dynamics, and its regulating kinases GSK3&#x03B2;, ERK1/2, p38 and LIMK1 were chosen as target proteins for studying the influence of A&#x03B2; isoforms (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Signaling cascades involved in actin polymerization/depolymerization discussed in this article.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Preparation of synthetic beta-amyloid peptides</title>
<p>Synthetic peptides [H2N]-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-[COOH] (&#x0410;&#x03B2;<sub>42</sub>), [H2N]-DAEFRHD[pS]GYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-[COOH] (pS8-&#x0410;&#x03B2;<sub>42</sub>) and [H2N]-DAEFRH[isoD]SGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-[COOH] (iso-&#x0410;&#x03B2;<sub>42</sub>) were obtained from Biopeptide (San Diego, CA, USA). Peptides were pre-monomerized by adding cold hexafluoroisopropanol (Fluka) to dry peptides to a concentration of 1&#x2009;mM and incubating for 60&#x2009;min at room temperature. The solutions were then aliquoted and dried in an Eppendorf 5,301 vacuum concentrator (Hamburg, Germany) for 20&#x2009;min. The obtained dry peptides were stored at &#x2212;20&#x00B0;C. Before the experiment, a 2.5&#x2009;mM stock solution of A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, or iso-A&#x03B2;<sub>42</sub> was prepared by adding 10&#x2009;&#x03BC;L of 100% anhydrous dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO, USA) to 0.12&#x2009;mg of peptide, followed by incubation for 1&#x2009;h at room temperature. The stock solution was then diluted to 10&#x2009;&#x03BC;M using serum-free RPMI-1640 medium.</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Cell culture</title>
<p>Experiments were performed on the human neuroblastoma cell line SH-SY5Y. Cells were cultured at 37&#x00B0;C in an atmosphere of 5% CO<sub>2</sub> in RPMI-1640 medium (Gibco) containing 1% GlutaMax (Gibco), 100&#x2009;U/mL penicillin and 100&#x2009;&#x03BC;g/mL streptomycin (PenStrep; Gibco), with the addition of 10% fetal bovine serum (FBS). For experiments, SH-SY5Y cells were incubated with 10&#x2009;&#x03BC;M A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, or iso-A&#x03B2;<sub>42</sub> or an equivalent amount of DMSO.</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>The amperometric detection of ROS using Pt-nanoelectrodes</title>
<p>The ROS concentration was determined by the amperometric method using Pt-nanoelectrodes. Fabrication of Pt-nanoelectrodes and single cell measurement process have been described in detail elsewhere (<xref ref-type="bibr" rid="ref16">Erofeev et al., 2018</xref>; <xref ref-type="bibr" rid="ref58">Vaneev et al., 2020</xref>).</p>
<p>Before experiments, SH-SY5Y (3&#x2009;&#x00D7;&#x2009;10<sup>5</sup>) were seeded in 35&#x2009;mm Petri dish and treated after night with beta-amyloid peptides for 4 or 24&#x2009;h. After the incubation time, attached cells in Petri dishes were washed three times by using Hanks&#x2019; Balanced Salt solution (HBSS) to remove the growth media and traces of amyloids. The total ROS level was calculated from the recorded intracellular average current value and calibration curve for each Pt-nanoelectrode.</p>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>Scanning ion-conductance microscopy</title>
<p>SICM by ICAPPIC (ICAPPIC ltd, United Kingdom) is used for topography and Young&#x2019;s modulus mapping of SH-SY5Y cells. Nanopipettes with 45&#x2013;50&#x2009;nm in radius was made from borosilicate glass O.D. 1.2&#x2009;mm, I.D. 0.69&#x2009;mm (WPI, United Kingdom) by using laser puller P-2000 (Sutter Instruments, USA). Nanopipette radius was calculated by using by following model (<xref ref-type="bibr" rid="ref14">Clarke et al., 2016</xref>):</p><disp-formula id="E1">
<mml:math id="M1">
<mml:mi>r</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mi mathvariant="italic">Io</mml:mi>
<mml:mrow>
<mml:mi mathvariant="italic">&#x03C0;Vktg</mml:mi>
<mml:mfenced open="(" close=")">
<mml:mi>&#x03B1;</mml:mi>
</mml:mfenced>
</mml:mrow>
</mml:mfrac>
</mml:math>
</disp-formula><p>where the half-cone angle <italic>&#x03B1;</italic> is 3 degrees, <italic>&#x03BA;</italic> is 1.35&#x2009;S&#x2009;m<sup>&#x2212;1</sup> and V is the applied electrical potential of 200&#x2009;mV.</p>
<p>A nanopipette was brought up close to the surface and scanned until the ion current through the tip decreased by 2% from its starting value in order to estimate the Young&#x2019;s modulus of living cells (<xref ref-type="bibr" rid="ref33">Kolmogorov et al., 2021</xref>). At an ion current decrease of 0.5%, a noncontact topographic image was obtained. Two more coordinates were obtained at ion current decreases (or set-points) of 1 and 2%, respectively, corresponding to membrane deformations induced by intrinsic force at each setpoint. Next, Young&#x2019;s modulus was calculated using the model shown below:</p><disp-formula id="E2">
<mml:math id="M2">
<mml:mi>E</mml:mi>
<mml:mo>=</mml:mo>
<mml:mi>P</mml:mi>
<mml:mi>A</mml:mi>
<mml:msup>
<mml:mfenced open="(" close=")">
<mml:mrow>
<mml:mfrac>
<mml:mi mathvariant="italic">Ssub</mml:mi>
<mml:mi mathvariant="italic">Scell</mml:mi>
</mml:mfrac>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mfenced>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:math>
</disp-formula><p>where <italic>E</italic> is the estimated Young&#x2019;s modulus, <italic>P</italic> is the applied pressure, A is a constant depending on the nanopipette geometry, and S<sub>sub</sub> and S<sub>cell</sub> are the slopes of the current&#x2013;distance curve observed between the ion current decreases of 1 and 2% at the non-deformable surface (S<sub>sub</sub> &#x2013; substrate) and cell surface (S<sub>cell</sub>), respectively. Cells were washed several times with Hank&#x2019;s solution (Gibco, USA) before scanning procedure. Cell density can influence Young&#x2019;s modulus (<xref ref-type="bibr" rid="ref54">Stroka and Aranda-Espinoza, 2011</xref>; <xref ref-type="bibr" rid="ref44">Nehls et al., 2019</xref>), and we confirmed this in our model (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>). To avoid such effect, all experiments with cell stiffness were performed using the same seeding density.</p>
</sec>
<sec id="sec7">
<label>2.5</label>
<title>Preparation of cell lysates to determine the degree of phosphorylation of signaling proteins</title>
<p>To determine the degree of phosphorylation of signaling proteins regulating the cytoskeleton, SH-SY5Y cells were seeded into wells of a 12-well plate (Greiner Bio-One) at 150 thousand per well and grown in RPMI-1640 medium with 10% FBS for 4&#x2009;days. Before the experiment, the cells were washed with serum-free RPMI-1640 medium (500&#x2009;&#x03BC;L per well), after which RPMI-1640 medium containing 10&#x2009;&#x03BC;M A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, iso-A&#x03B2;<sub>42</sub> or an equivalent amount of DMSO (control solution) was added (450&#x2009;&#x03BC;L per well) and incubated at 37&#x00B0;C in a CO<sub>2</sub> incubator (Eppendorf) for 30&#x2009;min, 2 or 4&#x2009;h. After the incubation time, the cells were washed 2 times with PBS (Gibco) at 500&#x2009;&#x03BC;L per well, the plate was cooled without liquid on ice for 5&#x2009;min, then frozen in liquid nitrogen and placed in a kelvinator (&#x2212;80&#x00B0;C) overnight. After that, 300&#x2009;&#x03BC;L of lysis buffer (Millipore) with the addition of a protease inhibitor (Roche) and a phosphatase inhibitor (Thermo Fisher Scientific) were added to the wells and incubated for 15&#x2009;min on ice. The cells were removed using a scraper, placed in 1.5&#x2009;mL test tubes and incubated for 1&#x2009;h at +4&#x00B0;&#x0421; with stirring. The cell lysate was centrifuged at 16,000&#x2009;g, +4&#x00B0;C, 10&#x2009;min (Eppendorf centrifuge, 5415R) and the supernatant was collected. The amount of total protein in the lysates was determined using a BCA assay kit (Sigma) according to the manufacturer&#x2019;s protocol.</p>
</sec>
<sec id="sec8">
<label>2.6</label>
<title>Western blot</title>
<p>The cell lysate was mixed with Tris-glycine sample buffer (Bio-Rad) containing 5% beta-mercaptoethanol and heated in a solid-state thermostat (bioSan, TDB-120) at 95&#x00B0;C for 5&#x2009;min. Proteins were separated in a 10% Tris-glycine polyacrylamide gel by Laemmli electrophoresis. Proteins were transferred using a semi-dry method (TransBlot Turbo, Bio-Rad) onto a 0.2&#x2009;&#x03BC;m nitrocellulose membrane (Bio-Rad) and blocked in a 5% skim milk solution (Diaem) in TBST (50&#x2009;mM Tis-HCl, pH 7.4, 150&#x2009;mM NaCl, 0.1% Tween-20) for 1&#x2009;h with stirring. The membranes were incubated with primary antibodies to the following proteins: (1) Cofilin (Cell Signaling Technology, D3F9, Rabbit, 5,175); (2) Phospho-Cofilin (Ser3) (Cell Signaling Technology, 77G2, Rabbit, 3,313); (3) LIMK1 (Cell Signaling Technology, Rabbit, 3,842); (4) Phospho-LIMK1 (Thr508)/LIMK2 (Thr505) (Cell Signaling Technology, Rabbit, 3,841); (5) GSK-3&#x03B2; (Cell Signaling Technology, D5C5Z, Rabbit, 12,456); (6) Phospho-GSK-3&#x03B2; (Ser9) (Cell Signaling Technology, D85E12, Rabbit, 5,558); beta actin (Abcam, ab8227). The membranes were incubated with primary antibodies overnight at +4&#x00B0;C with stirring, then washed in TBST and incubated with secondary antibodies to rabbit immunoglobulins conjugated with HRP (Hytest, 1:4,000) for 1&#x2009;h at room temperature with stirring. Membranes were visualized on a Bio-Rad ChemiDoc MP using Supersignal West Pico PLUS chemiluminescent substrate (ThermoFisher Scientific). Quantitative analysis was performed using Image Lab 6.0.1 software. Original blot images are presented in <xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>. To determine changes in the total level of kinases and cofilin, we normalized the total level of proteins of interest to the total protein content in the sample. The total protein content was calculated as follows: (sample volume loaded on &#x0430; gel) &#x002A; (protein concentration in the lysate measured by BCA) &#x002A; (dilution with loading buffer). Normalization by the levels of cytoskeletal proteins was not used because their levels changed under conditions of the experiment.</p>
</sec>
<sec id="sec9">
<label>2.7</label>
<title>Milliplex</title>
<p>Lysate samples were diluted 2-fold in Assay Buffer (Milliplex, Millipore) and the degree of kinase phosphorylation was determined using Milliplex kits measuring the total form (MILLIPLEX MAP Multi-Pathway Total Magnetic Bead 9-Plex, 48-681MAG, Millipore) or the phosphorylated form of ERK and p38 kinases (MILLIPLEX Multi-Pathway Magnetic Bead 9-Plex, 48-680MAG, Millipore) according to the manufacturer&#x2019;s protocol. Fluorescence intensity was measured on a MagPix instrument (Millipore) using calibration kits (MAGPIX Calibration Kit, Cat. No. MPX-CAL-K25), verification kits (MAGPIX Performance Verification Kit, Cat. No. MPX-PVER-K25) and xPONENT software, 4.3.229.0. Data processing was carried out using Belysa software v1.1.0 (Merck, Rahway, NJ, USA) at the Resource Center &#x201C;Cell Technology and Immunology,&#x201D; Sirius University of Science and Technology.</p>
</sec>
<sec id="sec10">
<label>2.8</label>
<title>Statistical data processing</title>
<p>Experimental data are presented as the mean of independent experiments &#x00B1; standard deviation (sd). The number of independent experiments is indicated in the figure legends. Statistical differences between experimental groups were determined using one-way ANOVA with Tukey&#x2019;s test for multiple comparisons. Differences were considered statistically significant at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05. Statistical analysis was performed using GraphPad Prism 8.0.1 software.</p>
</sec>
</sec>
<sec sec-type="results" id="sec11">
<label>3</label>
<title>Results</title>
<sec id="sec12">
<label>3.1</label>
<title>Effect of beta-amyloid isoforms on Young&#x2019;s modulus and ROS levels in SH-SY5Y</title>
<p>Cell stiffness is an important mechanical property and is measured as Young&#x2019;s modulus or elastic modulus (<xref ref-type="bibr" rid="ref38">Luo et al., 2016</xref>). When measuring the stiffness of SH-SY5Y cells using scanning ion-conductance microscopy (SICM), it was found that incubation with 10&#x2009;&#x03BC;M A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, iso-A&#x03B2;<sub>42</sub> resulted in a significant increase in the Young&#x2019;s modulus of the cells (<xref ref-type="fig" rid="fig2">Figure 2</xref>). After 4&#x2009;h of incubation, A&#x03B2;<sub>42</sub> had the greatest effect on cell stiffness, leading to a 6-fold increase in Young&#x2019;s modulus compared to the control. However, after 24&#x2009;h, Young&#x2019;s modulus was significantly reduced for all A&#x03B2; isoforms except pS8-A&#x03B2;<sub>42</sub>. A&#x03B2; is known to induce oxidative stress in various cells (<xref ref-type="bibr" rid="ref12">Butterfield, 2002</xref>; <xref ref-type="bibr" rid="ref27">Kadowaki et al., 2005</xref>). When measuring the ROS level in neuroblastoma cells, the maximum increase in ROS was recorded after incubation with pS8-A&#x03B2;<sub>42</sub>, leading to a 3-fold and 7-fold increase in ROS levels after 4 and 24&#x2009;h, respectively, compared to the control (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>(A) Topography and Young&#x2019;s modulus maps of SH-SY5Y cells incubated with different types of amyloids. Scale bar &#x2013; 10 um. E &#x2013; Young&#x2019;s modulus, Pa. (B) Schematic representation of the process of topography and Young&#x2019;s modulus measurements (C) Mean value &#x00B1; sd of Young&#x2019;s modulus of SH-SY5Y cells incubated with different types of &#x0410;&#x03B2;. Number of cells in each point &#x2212;40&#x2013;100, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,0001.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g002.tif"/>
</fig>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>(A) Schematic representation of the process of intracellular ROS measuring. (B) Visualization of current recording inside a single SH-SY5Y cell. (C) The mean total ROS level&#x2009;&#x00B1;&#x2009;sd of single SH-SY5Y cells incubated with different types of &#x0410;&#x03B2;. Number of cells in each point &#x2212;20&#x2013;30, &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,0001.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g003.tif"/>
</fig>
</sec>
<sec id="sec13">
<label>3.2</label>
<title>Beta-amyloid isoforms influence cofilin regulation</title>
<p>Having observed the increase in cell stiffness using SICM, we then studied the signaling cascades by which A&#x03B2; can lead to changes in the mechanical properties of SH-SY5Y cells. It is known that the organization of actin filaments is considered the most important factor determining cell stiffness (<xref ref-type="bibr" rid="ref38">Luo et al., 2016</xref>). Cofilin plays a significant role in the regulation of actin filament dynamics (<xref ref-type="bibr" rid="ref24">Heredia et al., 2006</xref>). We measured the levels of total cofilin and phosphorylated (inactivated) cofilin after incubation with A&#x03B2; isoforms. After 30&#x2009;min of incubation with beta-amyloid peptides, no changes in the ratio of phosphorylated cofilin to total cofilin (P-cofilin/cofilin) were detected (data not shown), but after 2&#x2009;h, in the presence of iso-A&#x03B2;<sub>42</sub>, this ratio was reduced by 45% compared to the control and by 40% compared to A&#x03B2;<sub>42</sub> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Thus, incubation with iso-A&#x03B2;<sub>42</sub> leads to dephosphorylation and activation of cofilin, which leads to actin depolymerization. It was also found that after 2&#x2009;h of incubation, exposure to A&#x03B2;<sub>42</sub> reduced cofilin expression by 35% compared to control, while exposure to iso-A&#x03B2;<sub>42</sub> increased cofilin expression by 40% compared to control (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). After 4&#x2009;h, no effect of A&#x03B2; isoforms on the level of cofilin expression was detected, however, pS8-A&#x03B2;<sub>42</sub> caused a 60% increase in the proportion of phosphorylated cofilin compared to iso-A&#x03B2;<sub>42</sub> (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Effect of beta-amyloid isoforms (&#x0410;&#x03B2;<sub>42</sub>, pS8-&#x0410;&#x03B2;<sub>42</sub>, iso-&#x0410;&#x03B2;<sub>42</sub>) at a concentration of 10&#x2009;&#x03BC;M on cofilin phosphorylation in SH-SY5Y cells after 2&#x2009;h (A) and 4&#x2009;h (B) of incubation with peptides. The ratio of phosphorylated cofilin to total cofilin (P-cofilin/cofilin) and the ratio of total cofilin to total protein content in the sample (Cofilin/protein) was calculated for every sample and normalized by the corresponding value in the control sample. Photographs of membranes obtained after Western blot stained with antibodies to total or phosphorylated cofilin are presented. The number of values in each group <italic>n</italic>&#x2009;=&#x2009;8&#x2013;9 (&#x0410;), <italic>n</italic>&#x2009;=&#x2009;5&#x2013;9 (&#x0412;), &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,0001.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g004.tif"/>
</fig>
<p>It is worth noting that A&#x03B2; isoforms do not lead to changes in actin expression levels neither at 30&#x2009;min, 2 or 4&#x2009;h of incubation (<xref ref-type="fig" rid="fig5">Figure 5</xref>). However, some studies suggest a dual role of cofilin in actin dynamics, indicating that actin filaments will be stabilized or destabilized depending on the ratio of cofilin to actin (<xref ref-type="bibr" rid="ref46">Pavlov et al., 2007</xref>; <xref ref-type="bibr" rid="ref45">Ohashi, 2015</xref>). Low concentration of cofilin promotes actin depolymerization, whereas high concentration of cofilin promotes actin nucleation and polymerization (<xref ref-type="bibr" rid="ref61">Wang et al., 2020</xref>). When measuring the cofilin to actin ratio, it was found that after 4&#x2009;h of incubation with A&#x03B2;<sub>42</sub> and pS8-A&#x03B2;<sub>42</sub>, the cofilin/actin ratio increased by 60 and 50% compared to the control, respectively (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). For iso-A&#x03B2;<sub>42</sub>, a tendency for this ratio to increase was also found.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Effect of beta-amyloid isoforms (&#x0410;&#x03B2;<sub>42</sub>, pS8-&#x0410;&#x03B2;<sub>42</sub>, iso-&#x0410;&#x03B2;<sub>42</sub>) at a concentration of 10&#x2009;&#x03BC;M on actin levels in SH-SY5Y cells. The ratio of actin band intensity to total protein content in the sample cells after 30&#x2009;min (A), 2&#x2009;h (B), and 4&#x2009;h (C) of incubation with peptides was calculated for every sample and normalized by the corresponding value in the control sample. (D) Western blot images of membranes stained with anti-beta-actin antibodies. (E) The ratio of cofilin to actin band intensities after 4&#x2009;h of incubation with beta-amyloid peptides. The number of values in each group <italic>n</italic>&#x2009;=&#x2009;3&#x2013;6, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,01.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g005.tif"/>
</fig>
</sec>
<sec id="sec14">
<label>3.3</label>
<title>Incubation with beta-amyloid isoforms leads to changes in the activity of kinases associated with the regulation of the actin cytoskeleton</title>
<p>Many protein kinases are involved in the regulation of cofilin, some of which are GSK3&#x03B2;, ERK1/2, p38 and LIMK1 (<xref ref-type="bibr" rid="ref25">Huang et al., 2007</xref>; <xref ref-type="bibr" rid="ref42">Mizuno, 2013</xref>; <xref ref-type="bibr" rid="ref5">Bamburg et al., 2021</xref>) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). GSK3&#x03B2; kinase phosphorylates tau and SSH phosphatase (<xref ref-type="bibr" rid="ref42">Mizuno, 2013</xref>) and thus participates in the regulation of cytoskeletal dynamics in neuronal cells; phosphorylation of the kinase leads to its inactivation. It was found that A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> caused an increase in the ratio of the phosphorylated form of GSK3&#x03B2; to total GSK3&#x03B2; (P-GSK3&#x03B2;/GSK3&#x03B2;) by 40% compared to the control after 30&#x2009;min of incubation (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). However, after 2&#x2009;h of incubation with A&#x03B2;<sub>42</sub>, the P-GSK3&#x03B2;/GSK3&#x03B2; ratio significantly decreased and became 30% lower compared to iso-A&#x03B2;<sub>42</sub> (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). It is worth noting that this corresponds to a decrease in the phosphorylated form of cofilin after 2&#x2009;h of incubation with iso-A&#x03B2;<sub>42</sub> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>): phosphorylation of GSK3&#x03B2; and its inactivation is accompanied by dephosphorylation and activation of SSH, which leads to dephosphorylation of cofilin (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Thus, the early effect of A&#x03B2;<sub>42</sub> leads to phosphorylation and, accordingly, inhibition of GSK3&#x03B2;, but then the reverse process occurs, leading to dephosphorylation of GSK3&#x03B2; and its activation. 30&#x2009;min after the start of incubation with beta-amyloid peptides, the level of the total form of this kinase also decreases by 15&#x2013;20% compared to the control. Importantly, the effects of A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, and iso-A&#x03B2;<sub>42</sub> on GSK3&#x03B2; phosphorylation differed, possibly indicating their different effects on the mechanical properties of SH-SY5Y. No changes in GSK3&#x03B2; phosphorylation were observed after 4&#x2009;h of incubation with beta-amyloid peptides (data not shown).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Effect of beta-amyloid isoforms (&#x0410;&#x03B2;<sub>42</sub>, pS8-&#x0410;&#x03B2;<sub>42</sub>, iso-&#x0410;&#x03B2;<sub>42</sub>) at a concentration of 10&#x2009;&#x03BC;M on GSK3&#x03B2; phosphorylation in SH-SY5Y cells after 30&#x2009;min (A) and 2&#x2009;h (B) of incubation with the peptides. The ratio of phosphorylated GSK3&#x03B2; to total GSK3&#x03B2; (P-GSK3&#x03B2;/GSK3&#x03B2;) and the ratio of total GSK3&#x03B2; to the total protein content in the sample (GSK3&#x03B2;/protein) was calculated for every sample and normalized by the corresponding value in the control sample. Photographs of membranes obtained after Western blot stained with antibodies to total or phosphorylated form of GSK3&#x03B2; are presented. The number of values in each group <italic>n</italic>&#x2009;=&#x2009;5&#x2013;6, &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,001.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g006.tif"/>
</fig>
<p>The kinases LIMK (<xref ref-type="bibr" rid="ref47">Pelucchi et al., 2020</xref>) and ERK (<xref ref-type="bibr" rid="ref13">Chatzifrangkeskou et al., 2018</xref>) phosphorylate cofilin, directly regulating its activity. Both kinases are activated by phosphorylation. Incubation with A&#x03B2;<sub>42</sub> was found to alter LIMK phosphorylation: P-LIMK/LIMK ratio was reduced by 45% compared to the control after 30&#x2009;min (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). After 4&#x2009;h of incubation with pS8-A&#x03B2;<sub>42</sub>, the P-LIMK/LIMK ratio increases by 60% compared to A&#x03B2;<sub>42</sub> (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). A tendency for this ratio to increase was also found for pS8-A&#x03B2;<sub>42</sub> compared to control (<xref ref-type="fig" rid="fig7">Figure 7B</xref>).</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Effect of beta-amyloid isoforms (&#x0410;&#x03B2;<sub>42</sub>, pS8-&#x0410;&#x03B2;<sub>42</sub>, iso-&#x0410;&#x03B2;<sub>42</sub>) at a concentration of 10&#x2009;&#x03BC;M on LIMK phosphorylation in SH-SY5Y cells after 30&#x2009;min (A) and 4&#x2009;h (B) of incubation with peptides. The ratio of phosphorylated LIMK to total LIMK (P-LIMK/LIMK) and the ratio of total LIMK to the total protein content in the sample (LIMK/protein) was calculated for every sample and normalized by the corresponding value in the control sample. Photographs of membranes obtained after Western blot stained with antibodies to total or phosphorylated LIMK are presented. The number of values in each group <italic>n</italic>&#x2009;=&#x2009;3 (&#x0410;), <italic>n</italic>&#x2009;=&#x2009;5&#x2013;6 (&#x0412;), &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,05.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g007.tif"/>
</fig>
<p>We showed that incubation with 10&#x2009;&#x03BC;M pS8-A&#x03B2;<sub>42</sub> resulted in a 60% increase in the ratio of phosphorylated ERK to total ERK (P-ERK/ERK) after 30&#x2009;min compared to the control (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Thus, changes in ERK1/2 activity under the influence of pS8-A&#x03B2;<sub>42</sub> can lead to changes in the cytoskeletal dynamics of SH-SY5Y cells.</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>Effect of beta-amyloid isoforms (&#x0410;&#x03B2;<sub>42</sub>, pS8-&#x0410;&#x03B2;<sub>42</sub>, iso-&#x0410;&#x03B2;<sub>42</sub>) at a concentration of 10&#x2009;&#x03BC;M on phosphorylation of ERK and p38 in SH-SY5Y cells after 30&#x2009;min of incubation with peptides. The ratios of the phosphorylated form to the total form calculated from the fluorescence intensity using Milliplex kits are presented. The number of values in each group <italic>n</italic>&#x2009;=&#x2009;5&#x2013;6, &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,05; &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0,01.</p>
</caption>
<graphic xlink:href="fnmol-17-1501874-g008.tif"/>
</fig>
<p>The activity of p38 kinase, whose neuronal targets include intermediate filament, microtubule, and actin network proteins, was also assessed (<xref ref-type="bibr" rid="ref3">Asih et al., 2020</xref>). P38 phosphorylates MAPK-activated protein kinase 2 (MK2) and subsequently activates LIMK, which in turn inhibits cofilin activity (<xref ref-type="bibr" rid="ref55">Sugiura et al., 2009</xref>). It was found that exposure to A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> reduces the degree of phosphorylation of this kinase after 30&#x2009;min of incubation by 25&#x2013;30% compared to the control (<xref ref-type="fig" rid="fig8">Figure 8</xref>). After 24&#x2009;h of incubation with beta-amyloid peptides, no statistically significant activation of ERK and p38 was observed, which correlates with the fact the cell stiffness also reduces to control levels in case of 24&#x2009;h A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> incubation (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref>). We also found that beta-amyloid isoforms lead to activation of the MAPK JNK after 30&#x2009;min and 4&#x2009;h of incubation (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3</xref>). However, no changes in the activation of NF-kB and Akt kinase were detected (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S4</xref>, <xref ref-type="supplementary-material" rid="SM1">S5</xref>).</p>
<p>The obtained effects of beta-amyloid isoforms are summarized in <xref ref-type="table" rid="tab1">Table 1</xref>.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Effect of A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, iso-A&#x03B2;<sub>42</sub> on the dynamics of the actin cytoskeleton in SH-SY5Y cells.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Kinase/protein</th>
<th align="left" valign="top">&#x0410;&#x03B2;</th>
<th align="left" valign="top">pS8</th>
<th align="left" valign="top">iso</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">GSK3&#x03B2;</td>
<td align="left" valign="top">Depolymerization (30&#x2009;min) Polymerization (2&#x2009;h)</td>
<td align="left" valign="top">Depolymerization (30&#x2009;min)</td>
<td align="left" valign="top">Depolymerization (30&#x2009;min)</td>
</tr>
<tr>
<td align="left" valign="top">Cofilin</td>
<td align="left" valign="top">Polymerization (2&#x2009;h) Polymerization (4&#x2009;h)</td>
<td align="left" valign="top">Polymerization (4&#x2009;h)</td>
<td align="left" valign="top">Depolymerization (2&#x2009;h) Polymerization (4&#x2009;h)</td>
</tr>
<tr>
<td align="left" valign="top">LIMK</td>
<td align="left" valign="top">&#x2013;</td>
<td align="left" valign="top">Polymerization (4&#x2009;h)</td>
<td align="left" valign="top">&#x2013;</td>
</tr>
<tr>
<td align="left" valign="top">Erk</td>
<td align="left" valign="top">&#x2013;</td>
<td align="left" valign="top">Polymerization (30&#x2009;min)</td>
<td align="left" valign="top">&#x2013;</td>
</tr>
<tr>
<td align="left" valign="top">&#x0440;38</td>
<td align="left" valign="top">Depolymerization (30&#x2009;min)</td>
<td align="left" valign="top">&#x2013;</td>
<td align="left" valign="top">Depolymerization (30&#x2009;min)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The contribution of various kinases and cofilin to actin polymerization/depolymerization after 30&#x2009;min, 2 and 4&#x2009;h of incubation is shown.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="sec15">
<label>4</label>
<title>Discussion</title>
<p>The mechanical properties of neuronal cells play a significant role in a wide range of biological functions, such as cellular homeostasis, proliferation, chemical and electrical signaling (<xref ref-type="bibr" rid="ref32">Kolmogorov V. et al., 2023</xref>). These properties are determined mainly by cytoskeletal elements: actin cytoskeleton, microtubules, intermediate filaments (<xref ref-type="bibr" rid="ref38">Luo et al., 2016</xref>). Oligomeric A&#x03B2; can alter cytoskeletal dynamics, which leads to changes in cell stiffness (<xref ref-type="bibr" rid="ref17">Gao et al., 2019</xref>), and also stimulates ROS production in neuronal cells (<xref ref-type="bibr" rid="ref60">Wang et al., 2010</xref>). In this work, the SICM method was used to measure the stiffness of SH-SY5Y cells in the presence of A&#x03B2; isoforms. Previously, using this method, it was established on SH-SY5Y cells that beta-amyloid leads to an increase in the Young&#x2019;s modulus of the entire cell (<xref ref-type="bibr" rid="ref31">Kolmogorov V. S. et al., 2023</xref>). We showed that A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, iso-A&#x03B2;<sub>42</sub> cause a significant increase in cell membrane stiffness, as well as an increase in the level of ROS (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3</xref>), which correlates with previously published data. The effects of beta-amyloid isoforms on these parameters differed: A&#x03B2;<sub>42</sub> led to the greatest increase in stiffness after 4&#x2009;h of incubation, and pS8-A&#x03B2;<sub>42</sub> led to the greatest increase in stiffness and ROS production in cells after 24&#x2009;h. At the same time, it is interesting that for A&#x03B2;<sub>42</sub> and pS8-A&#x03B2;<sub>42</sub>, in contrast to iso-A&#x03B2;<sub>42</sub>, there is a tendency for the ROS level to increase over time.</p>
<p>The actin cytoskeleton is known to play a key role in synaptic transmission and plasticity (<xref ref-type="bibr" rid="ref47">Pelucchi et al., 2020</xref>). Many studies have shown that disruption of the actin cytoskeleton using agents such as cytochalasin D, latrunculin A and latrunculin B results in a decrease in the Young&#x2019;s modulus of cells (<xref ref-type="bibr" rid="ref50">Roduit et al., 2009</xref>; <xref ref-type="bibr" rid="ref39">Mihai et al., 2012</xref>; <xref ref-type="bibr" rid="ref48">Pogoda et al., 2012</xref>; <xref ref-type="bibr" rid="ref37">Louise et al., 2014</xref>; <xref ref-type="bibr" rid="ref49">Ramos et al., 2014</xref>). It is worth noting that there is still no information on how much microtubules affect cell stiffness (<xref ref-type="bibr" rid="ref38">Luo et al., 2016</xref>), and the possibility of intermediate filaments to influence stiffness independently of the rearrangement of actin filaments remains questionable (<xref ref-type="bibr" rid="ref21">Gruenbaum and Aebi, 2014</xref>). Thus, the organization of actin filaments is considered to be the most important factor determining cell stiffness (<xref ref-type="bibr" rid="ref38">Luo et al., 2016</xref>), so in our work we focused specifically on this element of the cytoskeleton.</p>
<p>Several actin-binding proteins are known to be altered in AD brains and animal models of AD (<xref ref-type="bibr" rid="ref47">Pelucchi et al., 2020</xref>). Some of these important proteins are actin depolymerization factor (ADF) and cofilin. ADF/cofilin regulate actin filament dynamics (<xref ref-type="bibr" rid="ref24">Heredia et al., 2006</xref>). ADF/cofilin promote actin depolymerization and create a new pool of G-actin monomers available for the formation of new filaments, thus increasing the rate of actin filament turnover in cells (<xref ref-type="bibr" rid="ref52">Sarmiere and Bamburg, 2004</xref>; <xref ref-type="bibr" rid="ref10">Bernstein and Bamburg, 2010</xref>; <xref ref-type="bibr" rid="ref51">Rust, 2015</xref>). Since mammalian neurons contain approximately 5&#x2013;10 times more cofilin than ADF (<xref ref-type="bibr" rid="ref40">Minamide et al., 2000</xref>; <xref ref-type="bibr" rid="ref19">Garvalov et al., 2007</xref>), we focused specifically on cofilin. Cofilin is inactivated by phosphorylation of Ser3 by LIM kinase 1 (LIMK1) and activated by dephosphorylation of Ser3 by Slingshot family protein phosphatases (SSH) (<xref ref-type="bibr" rid="ref47">Pelucchi et al., 2020</xref>). We compared the effects of synthetic peptides A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub>, and iso-A&#x03B2;<sub>42</sub> on cofilin and its regulating kinases. We found that iso-A&#x03B2;<sub>42</sub> activated cofilin by dephosphorylation, whereas A&#x03B2;<sub>42</sub> and pS8-A&#x03B2;<sub>42</sub> did not cause such changes. A&#x03B2;<sub>40</sub> has previously been shown to increase the levels of Ser3-phosphorylated ADF/cofilin and Thr508-phosphorylated LIMK1 (P-LIMK1), which is accompanied by neuritic degeneration and neuronal cell death (<xref ref-type="bibr" rid="ref24">Heredia et al., 2006</xref>). However, it is worth noting that this study used fibrillar A&#x03B2;<sub>40</sub> and higher concentrations (20&#x2009;&#x03BC;M), while soluble forms of A&#x03B2;<sub>40</sub> did not change cofilin phosphorylation. Thus, it is possible that soluble A&#x03B2;<sub>40</sub> and A&#x03B2;<sub>42</sub> do not affect cofilin phosphorylation, in contrast to post-translationally modified forms of A&#x03B2;. At the same time, Kim et al. reported a decrease in cofilin phosphorylation in the brain of AD patients and in the forebrain of APP/PS1 mice, and also showed that the addition of A&#x03B2;<sub>42</sub> oligomers to cortical neuronal cultures causes cofilin activation (<xref ref-type="bibr" rid="ref30">Kim et al., 2013</xref>). These results are consistent with the activation of cofilin by iso-A&#x03B2;<sub>42</sub> established in our work: isomerized Asp7 is contained in more than 50% of A&#x03B2; molecules of amyloid plaques and is also enriched in the soluble fraction (<xref ref-type="bibr" rid="ref11">Bugrova et al., 2021</xref>; <xref ref-type="bibr" rid="ref43">Mukherjee et al., 2021</xref>), which explains the activation of cofilin in the brain of patients with AD and <italic>in vivo</italic> models of AD. The activation of cofilin only by iso-A&#x03B2;<sub>42</sub> may be one of the reasons for the greater toxicity of this isoform observed in many studies (<xref ref-type="bibr" rid="ref41">Mitkevich et al., 2013</xref>). The researchers also note that the state of cofilin phosphorylation depends on both age and the stage of AD pathology (<xref ref-type="bibr" rid="ref6">Barone et al., 2014</xref>). Interestingly, not only cofilin phosphorylation but also the cofilin to actin ratio influences actin filament stabilization. As the cofilin/actin ratio increases, cofilin triggers actin assembly and stabilizes the filaments (<xref ref-type="bibr" rid="ref2">Andrianantoandro and Pollard, 2006</xref>; <xref ref-type="bibr" rid="ref4">Bamburg and Bloom, 2009</xref>). We found that all beta-amyloid isoforms increased the cofilin/actin ratio after 4&#x2009;h of incubation with the peptides, indicating polymerization of actin filaments and consistent with the increase in cell stiffness measured by SICM.</p>
<p>We also found differences in the effects of A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> on the activity of cofilin-regulating kinases after 30&#x2009;min of incubation: inhibition of GSK3&#x03B2; (A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub>), inactivation of p38 (A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub>). This leads to actin depolymerization, but the signaling pathways that cause this effect differ. Interestingly, pS8-A&#x03B2;<sub>42</sub> appears to have a different signaling cascade via Erk activation, leading to actin polymerization. It is worth noting that this A&#x03B2; isoform had a distinctive pattern of effects on stiffness: after 4&#x2009;h, pS8-A&#x03B2;<sub>42</sub> caused a significantly smaller increase in the Young&#x2019;s modulus of cells than A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub>, but after 24&#x2009;h, pS8-A&#x03B2;<sub>42</sub> led to greater stiffness than the other isoforms. One of the reasons for these differences in A&#x03B2; isoforms may be the activation of different signaling cascades. It has been previously shown that some pathogenic properties of A&#x03B2; are neutralized by its phosphorylation (<xref ref-type="bibr" rid="ref26">Jamasbi et al., 2017</xref>; <xref ref-type="bibr" rid="ref9">Barykin et al., 2018</xref>). The activation of a different signaling pathway from other isoforms may be responsible for altered pathogenic properties of pS8-A&#x03B2;<sub>42</sub>. After 4&#x2009;h, a change in signaling protein activation occurs, leading to actin polymerization and corresponding to an increase in cell stiffness measured by SICM. This discrepancy, at first glance, is explained by the fact that the rupture and depolymerization of actin filaments promotes an increase in the concentration of G-actin and the formation of free barbed ends of the filaments, which is necessary for the rapid reorganization of the actin cytoskeleton and further polymerization of actin (<xref ref-type="bibr" rid="ref42">Mizuno, 2013</xref>; <xref ref-type="bibr" rid="ref47">Pelucchi et al., 2020</xref>). It should be noted that the role of LIMK in cofilin regulation is ambiguous. Thus, it has been shown that A&#x03B2;<sub>1&#x2013;40</sub> and A&#x03B2;<sub>25&#x2013;35</sub> fibrils induce LIMK activation, which leads to cofilin inactivation (<xref ref-type="bibr" rid="ref24">Heredia et al., 2006</xref>). However, A&#x03B2;<sub>1&#x2013;42</sub> was also found to activate LIMK1, which was paradoxically associated with increased cofilin activation, suggesting other pathways of cofilin regulation by A&#x03B2; (e.g., SSH1) (<xref ref-type="bibr" rid="ref61">Wang et al., 2020</xref>; <xref ref-type="bibr" rid="ref28">Kang and Woo, 2019</xref>). It has also been shown that cofilin activation is increased in AD with a simultaneous lack of changes in LIMK activation (<xref ref-type="bibr" rid="ref30">Kim et al., 2013</xref>), which is consistent with our results.</p>
<p>It is known that ROS are not only damaging agents, but also mediators involved in cellular signaling and regulation (<xref ref-type="bibr" rid="ref15">Corcoran and Cotter, 2013</xref>). ROS can affect cell stiffness in several ways (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S6</xref>). In current study we focused on signaling cascades regulating actin cytoskeleton that can be induced by ROS. Thus, the activity of MAP kinases such as p38 and ERK can be regulated by ROS (<xref ref-type="bibr" rid="ref53">Son et al., 2013</xref>; <xref ref-type="bibr" rid="ref62">Zhang et al., 2016</xref>). Activation of p38 by ROS can affect the cytoskeleton both through cofilin (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and through phosphorylation of the heat shock protein HSP27, which regulates microfilament dynamics, the redox state of actin, and some actin regulatory proteins (<xref ref-type="bibr" rid="ref22">Guay et al., 1997</xref>, p. 27). At the same time, ERK, after stimulation by ROS, is able to activate actin regulatory complexes, which leads to actin polymerization (<xref ref-type="bibr" rid="ref56">Taulet et al., 2012</xref>). Interestingly, pS8-A&#x03B2;<sub>42</sub> caused the maximum increase in ROS observed in SH-SY5Y cells (<xref ref-type="fig" rid="fig3">Figure 3</xref>), while only pS8-A&#x03B2;<sub>42</sub> led to ERK activation in our experiment (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Hence, significant ERK activation by pS8-A&#x03B2;<sub>42</sub> could be in part mediated by stimulated production of ROS. The researchers also note that oxidative stress activates GSK3&#x03B2; (<xref ref-type="bibr" rid="ref62">Zhang et al., 2016</xref>), which plays an important role in both actin filament regulation and microtubule regulation. However, we did not observe these effects. It is known that ROS, through the oxidation of 14&#x2013;3-3zeta, activate cofilin phosphatase, which leads to dephosphorylation and activation of cofilin (<xref ref-type="bibr" rid="ref29">Kim et al., 2009</xref>). In addition to actin, ROS can also affect cell stiffness through other cytoskeletal elements. Thus, oxidative stress suppresses microtubule-associated proteins and affects tubulin through post-translational modifications. Neurofilaments become phosphorylated during oxidative stress, leading to the formation of protein aggregates (<xref ref-type="bibr" rid="ref18">Gardiner et al., 2013</xref>). ROS are known to activate the MAP kinase JNK via several pathways (<xref ref-type="bibr" rid="ref62">Zhang et al., 2016</xref>). We found that A&#x03B2; isoforms activate JNK (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3</xref>), which corresponds to increased ROS levels in SH-SY5Y cells (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Signaling pathways such as NF-&#x03BA;B and PI3K-Akt also depend on ROS (<xref ref-type="bibr" rid="ref62">Zhang et al., 2016</xref>), however, we did not detect activation of NF-&#x03BA;B factor and Akt kinase (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S4</xref>, <xref ref-type="supplementary-material" rid="SM1">S5</xref>). Thus, beta-amyloid peptides used in our investigation do not activate the NF-&#x03BA;B and PI3K-Akt pathways in SH-SY5Y cells.</p>
<p>Reactive oxygen species are able to influence the reorganization of the actin cytoskeleton not only indirectly (via redox-sensitive enzymes), but also by direct oxidative modifications of actin. The researchers note that actin filaments can use oxidative stress for their reorganization in a context-dependent way, as oxidative stress can either increase cellular actin aggregation (<xref ref-type="bibr" rid="ref18">Gardiner et al., 2013</xref>) or reduce the rate of filament formation via S-glutathionylation of actin (<xref ref-type="bibr" rid="ref23">Haseena et al., 2022</xref>). In a mouse model of AD, a role of A&#x03B2;-induced oxidative stress in actin glutathionylation and F-actin reduction has been demonstrated (<xref ref-type="bibr" rid="ref34">Kommaddi et al., 2019</xref>). It is also noted that deglutathionylation of G-actin leads to a 6-fold increase in the rate of polymerization (<xref ref-type="bibr" rid="ref59">Wang et al., 2001</xref>). Thus, the effect of ROS on actin polymerization and, accordingly, cell stiffness is ambiguous and may depend on the cell type and additional regulatory mechanisms. Although depolymerization of actin filaments leads to a decrease in the Young&#x2019;s modulus of cells, polymerization of actin filaments is not the only factor determining cell stiffness, and it is necessary to take the spatial organization of actin filaments into account (<xref ref-type="bibr" rid="ref38">Luo et al., 2016</xref>).</p>
</sec>
<sec sec-type="conclusions" id="sec16">
<label>5</label>
<title>Conclusion</title>
<p>In this work, it is shown that the effects of A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> on signaling cascades associated with the regulation of mechanical properties of cells are different. This leads to the fact that, depending on the post-translational modification that the A&#x03B2; molecule acquires, beta-amyloid increases the Young&#x2019;s modulus of the SH-SY5Y cell membrane and the level of ROS to varying degrees. Based on the obtained data, we proposed mechanisms mediating the effect of beta-amyloid peptide and its modified forms on the mechanical properties of neuronal cells. Thus, we showed that A&#x03B2; and its isoforms differently affect the activity of proteins that regulate the actin cytoskeleton, such as cofilin, GSK3<italic>&#x03B2;</italic>, LIMK, ERK and p38. We found that short-term incubation with beta-amyloid peptides activates signaling pathways that stimulate actin depolymerization, with the exception of ERK for pS8-A&#x03B2;<sub>42</sub>, while longer incubation results in activation of signaling cascades that lead to actin polymerization. In this case, pS8-A&#x03B2;<sub>42</sub> has the most stable effect on cell stiffness. These results may explain the reasons for the different pathogenicity of A&#x03B2;<sub>42</sub>, pS8-A&#x03B2;<sub>42</sub> and iso-A&#x03B2;<sub>42</sub> for neuronal cells, which is important for a complete understanding of AD pathology.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec17">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="sec18">
<title>Author contributions</title>
<p>KV: Formal analysis, Investigation, Methodology, Visualization, Writing &#x2013; original draft. EB: Data curation, Methodology, Writing &#x2013; review &#x0026; editing. RT: Investigation, Methodology, Writing &#x2013; original draft. VK: Investigation, Methodology, Writing &#x2013; original draft. AE: Conceptualization, Project administration, Resources, Supervision, Writing &#x2013; review &#x0026; editing. PG: Investigation, Methodology, Writing &#x2013; review &#x0026; editing. VM: Conceptualization, Project administration, Resources, Supervision, Writing &#x2013; review &#x0026; editing. AM: Funding acquisition, Resources, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec19">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Ministry of Education and Science of the Russian Federation, Agreement No. 075-15-2022-264.</p>
</sec>
<sec sec-type="COI-statement" id="sec20">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec21">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec22">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2024.1501874/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnmol.2024.1501874/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname> <given-names>R.</given-names></name> <name><surname>Gill</surname> <given-names>K. D.</given-names></name> <name><surname>Mahdi</surname> <given-names>A. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Therapeutics of Alzheimer&#x2019;s disease: past, present and future</article-title>. <source>Neuropharmacology</source> <volume>76</volume>, <fpage>27</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.07.004</pub-id></citation>
</ref>
<ref id="ref2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrianantoandro</surname> <given-names>E.</given-names></name> <name><surname>Pollard</surname> <given-names>T. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin</article-title>. <source>Mol. Cell</source> <volume>24</volume>, <fpage>13</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2006.08.006</pub-id>, PMID: <pub-id pub-id-type="pmid">17018289</pub-id></citation>
</ref>
<ref id="ref3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asih</surname> <given-names>P. R.</given-names></name> <name><surname>Prikas</surname> <given-names>E.</given-names></name> <name><surname>Stefanoska</surname> <given-names>K.</given-names></name> <name><surname>Tan</surname> <given-names>A. R. P.</given-names></name> <name><surname>Ahel</surname> <given-names>H. I.</given-names></name> <name><surname>Ittner</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Functions of p38 MAP kinases in the central nervous system</article-title>. <source>Front. Mol. Neurosci.</source> <volume>13</volume>:<fpage>570586</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnmol.2020.570586</pub-id>, PMID: <pub-id pub-id-type="pmid">33013322</pub-id></citation>
</ref>
<ref id="ref4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bamburg</surname> <given-names>J. R.</given-names></name> <name><surname>Bloom</surname> <given-names>G. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Cytoskeletal pathologies of Alzheimer disease</article-title>. <source>Cell Motil.</source> <volume>66</volume>, <fpage>635</fpage>&#x2013;<lpage>649</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cm.20388</pub-id>, PMID: <pub-id pub-id-type="pmid">19479823</pub-id></citation>
</ref>
<ref id="ref5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bamburg</surname> <given-names>J. R.</given-names></name> <name><surname>Minamide</surname> <given-names>L. S.</given-names></name> <name><surname>Wiggan</surname> <given-names>O.</given-names></name> <name><surname>Tahtamouni</surname> <given-names>L. H.</given-names></name> <name><surname>Kuhn</surname> <given-names>T. B.</given-names></name></person-group> (<year>2021</year>). <article-title>Cofilin and actin dynamics: multiple modes of regulation and their impacts in neuronal development and degeneration</article-title>. <source>Cells</source> <volume>10</volume>:<fpage>2726</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cells10102726</pub-id>, PMID: <pub-id pub-id-type="pmid">34685706</pub-id></citation>
</ref>
<ref id="ref6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barone</surname> <given-names>E.</given-names></name> <name><surname>Mosser</surname> <given-names>S.</given-names></name> <name><surname>Fraering</surname> <given-names>P. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Inactivation of brain Cofilin-1 by age, Alzheimer&#x2019;s disease and &#x03B3;-secretase</article-title>. <source>Biochim. Biophys. Acta Mol. Basis Dis.</source> <volume>1842</volume>, <fpage>2500</fpage>&#x2013;<lpage>2509</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbadis.2014.10.004</pub-id>, PMID: <pub-id pub-id-type="pmid">25315299</pub-id></citation>
</ref>
<ref id="ref7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barykin</surname> <given-names>E. P.</given-names></name> <name><surname>Garifulina</surname> <given-names>A. I.</given-names></name> <name><surname>Kruykova</surname> <given-names>E. V.</given-names></name> <name><surname>Spirova</surname> <given-names>E. N.</given-names></name> <name><surname>Anashkina</surname> <given-names>A. A.</given-names></name> <name><surname>Adzhubei</surname> <given-names>A. A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Isomerization of Asp7 in Beta-amyloid enhances inhibition of the &#x03B1;7 nicotinic receptor and promotes neurotoxicity</article-title>. <source>Cells</source> <volume>8</volume>:<fpage>771</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cells8080771</pub-id>, PMID: <pub-id pub-id-type="pmid">31349637</pub-id></citation>
</ref>
<ref id="ref8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barykin</surname> <given-names>E. P.</given-names></name> <name><surname>Mitkevich</surname> <given-names>V. A.</given-names></name> <name><surname>Kozin</surname> <given-names>S. A.</given-names></name> <name><surname>Makarov</surname> <given-names>A. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Amyloid &#x03B2; modification: A key to the sporadic Alzheimer&#x2019;s disease?</article-title> <source>Front. Genet.</source> <volume>8</volume>:<fpage>58</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fgene.2017.00058</pub-id>, PMID: <pub-id pub-id-type="pmid">28555154</pub-id></citation>
</ref>
<ref id="ref9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barykin</surname> <given-names>E. P.</given-names></name> <name><surname>Petrushanko</surname> <given-names>I. Y.</given-names></name> <name><surname>Kozin</surname> <given-names>S. A.</given-names></name> <name><surname>Telegin</surname> <given-names>G. B.</given-names></name> <name><surname>Chernov</surname> <given-names>A. S.</given-names></name> <name><surname>Lopina</surname> <given-names>O. D.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Phosphorylation of the amyloid-Beta peptide inhibits zinc-dependent aggregation, prevents Na,K-ATPase inhibition, and reduces cerebral plaque deposition</article-title>. <source>Front. Mol. Neurosci.</source> <volume>11</volume>:<fpage>302</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnmol.2018.00302</pub-id>, PMID: <pub-id pub-id-type="pmid">30210292</pub-id></citation>
</ref>
<ref id="ref10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname> <given-names>B. W.</given-names></name> <name><surname>Bamburg</surname> <given-names>J. R.</given-names></name></person-group> (<year>2010</year>). <article-title>ADF/cofilin: a functional node in cell biology</article-title>. <source>Trends Cell Biol.</source> <volume>20</volume>, <fpage>187</fpage>&#x2013;<lpage>195</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tcb.2010.01.001</pub-id>, PMID: <pub-id pub-id-type="pmid">20133134</pub-id></citation>
</ref>
<ref id="ref11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bugrova</surname> <given-names>A. E.</given-names></name> <name><surname>Strelnikova</surname> <given-names>P. A.</given-names></name> <name><surname>Indeykina</surname> <given-names>M. I.</given-names></name> <name><surname>Kononikhin</surname> <given-names>A. S.</given-names></name> <name><surname>Zakharova</surname> <given-names>N. V.</given-names></name> <name><surname>Brzhozovskiy</surname> <given-names>A. G.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>The dynamics of &#x03B2;-amyloid Proteoforms accumulation in the brain of a 5xFAD mouse model of Alzheimer&#x2019;s disease</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>:<fpage>27</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms23010027</pub-id>, PMID: <pub-id pub-id-type="pmid">35008451</pub-id></citation>
</ref>
<ref id="ref12">
<citation citation-type="journal"><person-group person-group-type="author">
<name><surname>Butterfield</surname> <given-names>D. A.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer&#x2019;s disease brain A review</article-title>. <source>Free Radic. Res.</source> <volume>36</volume>, <fpage>1307</fpage>&#x2013;<lpage>1313</lpage>. doi: <pub-id pub-id-type="doi">10.1080/1071576021000049890</pub-id></citation>
</ref>
<ref id="ref13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatzifrangkeskou</surname> <given-names>M.</given-names></name> <name><surname>Yadin</surname> <given-names>D.</given-names></name> <name><surname>Marais</surname> <given-names>T.</given-names></name> <name><surname>Chardonnet</surname> <given-names>S.</given-names></name> <name><surname>Cohen-Tannoudji</surname> <given-names>M.</given-names></name> <name><surname>Mougenot</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by Lamin A/C gene mutation</article-title>. <source>Hum. Mol. Genet.</source> <volume>27</volume>, <fpage>3060</fpage>&#x2013;<lpage>3078</lpage>. doi: <pub-id pub-id-type="doi">10.1093/hmg/ddy215</pub-id>, PMID: <pub-id pub-id-type="pmid">29878125</pub-id></citation>
</ref>
<ref id="ref14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname> <given-names>R. W.</given-names></name> <name><surname>Novak</surname> <given-names>P.</given-names></name> <name><surname>Zhukov</surname> <given-names>A.</given-names></name> <name><surname>Tyler</surname> <given-names>E. J.</given-names></name> <name><surname>Cano-Jaimez</surname> <given-names>M.</given-names></name> <name><surname>Drews</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Low stress ion conductance microscopy of sub-cellular stiffness</article-title>. <source>Soft Matter</source> <volume>12</volume>, <fpage>7953</fpage>&#x2013;<lpage>7958</lpage>. doi: <pub-id pub-id-type="doi">10.1039/C6SM01106C</pub-id>, PMID: <pub-id pub-id-type="pmid">27604678</pub-id></citation>
</ref>
<ref id="ref15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corcoran</surname> <given-names>A.</given-names></name> <name><surname>Cotter</surname> <given-names>T. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Redox regulation of protein kinases</article-title>. <source>FEBS J.</source> <volume>280</volume>, <fpage>1944</fpage>&#x2013;<lpage>1965</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.12224</pub-id></citation>
</ref>
<ref id="ref16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erofeev</surname> <given-names>A.</given-names></name> <name><surname>Gorelkin</surname> <given-names>P.</given-names></name> <name><surname>Garanina</surname> <given-names>A.</given-names></name> <name><surname>Alova</surname> <given-names>A.</given-names></name> <name><surname>Efremova</surname> <given-names>M.</given-names></name> <name><surname>Vorobyeva</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Novel method for rapid toxicity screening of magnetic nanoparticles</article-title>. <source>Sci. Rep.</source> <volume>8</volume>:<fpage>7462</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-25852-4</pub-id>, PMID: <pub-id pub-id-type="pmid">29748550</pub-id></citation>
</ref>
<ref id="ref17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>Q.</given-names></name> <name><surname>Fang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Wong</surname> <given-names>H. S. H.</given-names></name> <name><surname>Chan</surname> <given-names>Y. E.</given-names></name> <name><surname>Wong</surname> <given-names>S. S. M.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Dynamic effect of beta-amyloid 42 on cell mechanics</article-title>. <source>J. Biomech.</source> <volume>86</volume>, <fpage>79</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jbiomech.2019.01.046</pub-id>, PMID: <pub-id pub-id-type="pmid">30770196</pub-id></citation>
</ref>
<ref id="ref18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname> <given-names>J.</given-names></name> <name><surname>Overall</surname> <given-names>R.</given-names></name> <name><surname>Marc</surname> <given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>The nervous system cytoskeleton under oxidative stress</article-title>. <source>Diseases</source> <volume>1</volume>, <fpage>36</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.3390/diseases1010036</pub-id></citation>
</ref>
<ref id="ref19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garvalov</surname> <given-names>B. K.</given-names></name> <name><surname>Flynn</surname> <given-names>K. C.</given-names></name> <name><surname>Neukirchen</surname> <given-names>D.</given-names></name> <name><surname>Meyn</surname> <given-names>L.</given-names></name> <name><surname>Teusch</surname> <given-names>N.</given-names></name> <name><surname>Wu</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Cdc42 regulates cofilin during the establishment of neuronal polarity</article-title>. <source>J. Neurosci.</source> <volume>27</volume>, <fpage>13117</fpage>&#x2013;<lpage>13129</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3322-07.2007</pub-id>, PMID: <pub-id pub-id-type="pmid">18045906</pub-id></citation>
</ref>
<ref id="ref20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gnoth</surname> <given-names>K.</given-names></name> <name><surname>Piechotta</surname> <given-names>A.</given-names></name> <name><surname>Kleinschmidt</surname> <given-names>M.</given-names></name> <name><surname>Konrath</surname> <given-names>S.</given-names></name> <name><surname>Schenk</surname> <given-names>M.</given-names></name> <name><surname>Taudte</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Targeting isoaspartate-modified A&#x03B2; rescues behavioral deficits in transgenic mice with Alzheimer&#x2019;s disease-like pathology</article-title>. <source>Alzheimers Res. Ther.</source> <volume>12</volume>:<fpage>149</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13195-020-00719-x</pub-id>, PMID: <pub-id pub-id-type="pmid">33189132</pub-id></citation>
</ref>
<ref id="ref21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gruenbaum</surname> <given-names>Y.</given-names></name> <name><surname>Aebi</surname> <given-names>U.</given-names></name></person-group> (<year>2014</year>). <article-title>Intermediate filaments: a dynamic network that controls cell mechanics</article-title>. <source>F1000Prime Rep.</source> <volume>6</volume>:<fpage>54</fpage>. doi: <pub-id pub-id-type="doi">10.12703/P6-54</pub-id>, PMID: <pub-id pub-id-type="pmid">25184044</pub-id></citation>
</ref>
<ref id="ref22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guay</surname> <given-names>J.</given-names></name> <name><surname>Lambert</surname> <given-names>H.</given-names></name> <name><surname>Gingras-Breton</surname> <given-names>G.</given-names></name> <name><surname>Lavoie</surname> <given-names>J. N.</given-names></name> <name><surname>Huot</surname> <given-names>J.</given-names></name> <name><surname>Landry</surname> <given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27</article-title>. <source>J. Cell Sci.</source> <volume>110</volume>, <fpage>357</fpage>&#x2013;<lpage>368</lpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.110.3.357</pub-id>, PMID: <pub-id pub-id-type="pmid">9057088</pub-id></citation>
</ref>
<ref id="ref23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haseena</surname> <given-names>P. A.</given-names></name> <name><surname>Diwakar</surname> <given-names>L.</given-names></name> <name><surname>Ravindranath</surname> <given-names>V.</given-names></name></person-group> (<year>2022</year>). <article-title>Protein Glutathionylation and Glutaredoxin: role in neurodegenerative diseases</article-title>. <source>Antioxidants</source> <volume>11</volume>:<fpage>2334</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox11122334</pub-id>, PMID: <pub-id pub-id-type="pmid">36552543</pub-id></citation>
</ref>
<ref id="ref24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heredia</surname> <given-names>L.</given-names></name> <name><surname>Helguera</surname> <given-names>P.</given-names></name> <name><surname>de Olmos</surname> <given-names>S.</given-names></name> <name><surname>Kedikian</surname> <given-names>G.</given-names></name> <name><surname>Sol&#x00E1; Vigo</surname> <given-names>F.</given-names></name> <name><surname>LaFerla</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer&#x2019;s disease</article-title>. <source>J. Neurosci.</source> <volume>26</volume>, <fpage>6533</fpage>&#x2013;<lpage>6542</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5567-05.2006</pub-id></citation>
</ref>
<ref id="ref25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>F.</given-names></name> <name><surname>Chotiner</surname> <given-names>J. K.</given-names></name> <name><surname>Steward</surname> <given-names>O.</given-names></name></person-group> (<year>2007</year>). <article-title>Actin polymerization and ERK phosphorylation are required for arc/Arg3.1 mRNA targeting to activated synaptic sites on dendrites</article-title>. <source>J. Neurosci.</source> <volume>27</volume>, <fpage>9054</fpage>&#x2013;<lpage>9067</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2410-07.2007</pub-id></citation>
</ref>
<ref id="ref26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jamasbi</surname> <given-names>E.</given-names></name> <name><surname>Separovic</surname> <given-names>F.</given-names></name> <name><surname>Hossain</surname> <given-names>M. A.</given-names></name> <name><surname>Ciccotosto</surname> <given-names>G. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Phosphorylation of a full length amyloid-&#x03B2; peptide modulates its amyloid aggregation, cell binding and neurotoxic properties</article-title>. <source>Mol. BioSyst.</source> <volume>13</volume>, <fpage>1545</fpage>&#x2013;<lpage>1551</lpage>. doi: <pub-id pub-id-type="doi">10.1039/C7MB00249A</pub-id></citation>
</ref>
<ref id="ref27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadowaki</surname> <given-names>H.</given-names></name> <name><surname>Nishitoh</surname> <given-names>H.</given-names></name> <name><surname>Urano</surname> <given-names>F.</given-names></name> <name><surname>Sadamitsu</surname> <given-names>C.</given-names></name> <name><surname>Matsuzawa</surname> <given-names>A.</given-names></name> <name><surname>Takeda</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Amyloid &#x03B2; induces neuronal cell death through ROS-mediated ASK1 activation</article-title>. <source>Cell Death Differ.</source> <volume>12</volume>, <fpage>19</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.cdd.4401528</pub-id></citation>
</ref>
<ref id="ref28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>D. E.</given-names></name> <name><surname>Woo</surname> <given-names>J. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Cofilin, a master node regulating cytoskeletal pathogenesis in Alzheimer&#x2019;s disease</article-title>. <source>J. Alzheimers Dis.</source> <volume>72</volume>, <fpage>S131</fpage>&#x2013;<lpage>S144</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-190585</pub-id>, PMID: <pub-id pub-id-type="pmid">31594228</pub-id></citation>
</ref>
<ref id="ref29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J.-S.</given-names></name> <name><surname>Huang</surname> <given-names>T. Y.</given-names></name> <name><surname>Bokoch</surname> <given-names>G. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Reactive oxygen species regulate a slingshot-Cofilin activation pathway</article-title>. <source>MBoC</source> <volume>20</volume>, <fpage>2650</fpage>&#x2013;<lpage>2660</lpage>. doi: <pub-id pub-id-type="doi">10.1091/mbc.e09-02-0131</pub-id>, PMID: <pub-id pub-id-type="pmid">19339277</pub-id></citation>
</ref>
<ref id="ref30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>T.</given-names></name> <name><surname>Vidal</surname> <given-names>G. S.</given-names></name> <name><surname>Djurisic</surname> <given-names>M.</given-names></name> <name><surname>William</surname> <given-names>C. M.</given-names></name> <name><surname>Birnbaum</surname> <given-names>M. E.</given-names></name> <name><surname>Garcia</surname> <given-names>K. C.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Human LilrB2 is a &#x03B2;-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer&#x2019;s model</article-title>. <source>Science</source> <volume>341</volume>, <fpage>1399</fpage>&#x2013;<lpage>1404</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1242077</pub-id>, PMID: <pub-id pub-id-type="pmid">24052308</pub-id></citation>
</ref>
<ref id="ref31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolmogorov</surname> <given-names>V. S.</given-names></name> <name><surname>Erofeev</surname> <given-names>A. S.</given-names></name> <name><surname>Barykin</surname> <given-names>E. P.</given-names></name> <name><surname>Timoshenko</surname> <given-names>R. V.</given-names></name> <name><surname>Lopatukhina</surname> <given-names>E. V.</given-names></name> <name><surname>Kozin</surname> <given-names>S. A.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Scanning ion-conductance microscopy for studying &#x03B2;-amyloid aggregate formation on living cell surfaces</article-title>. <source>Anal. Chem.</source> <volume>95</volume>, <fpage>15943</fpage>&#x2013;<lpage>15949</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.analchem.3c02806</pub-id>, PMID: <pub-id pub-id-type="pmid">37856787</pub-id></citation>
</ref>
<ref id="ref32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolmogorov</surname> <given-names>V.</given-names></name> <name><surname>Erofeev</surname> <given-names>A.</given-names></name> <name><surname>Vaneev</surname> <given-names>A.</given-names></name> <name><surname>Gorbacheva</surname> <given-names>L.</given-names></name> <name><surname>Kolesov</surname> <given-names>D.</given-names></name> <name><surname>Klyachko</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Scanning ion-conductance microscopy for studying mechanical properties of neuronal cells during local delivery of glutamate</article-title>. <source>Cells</source> <volume>12</volume>:<fpage>2428</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cells12202428</pub-id>, PMID: <pub-id pub-id-type="pmid">37887273</pub-id></citation>
</ref>
<ref id="ref33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolmogorov</surname> <given-names>V. S.</given-names></name> <name><surname>Erofeev</surname> <given-names>A. S.</given-names></name> <name><surname>Woodcock</surname> <given-names>E.</given-names></name> <name><surname>Efremov</surname> <given-names>Y. M.</given-names></name> <name><surname>Iakovlev</surname> <given-names>A. P.</given-names></name> <name><surname>Savin</surname> <given-names>N. A.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Mapping mechanical properties of living cells at nanoscale using intrinsic nanopipette-sample force interactions</article-title>. <source>Nanoscale</source> <volume>13</volume>, <fpage>6558</fpage>&#x2013;<lpage>6568</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d0nr08349f</pub-id>, PMID: <pub-id pub-id-type="pmid">33885535</pub-id></citation>
</ref>
<ref id="ref34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kommaddi</surname> <given-names>R. P.</given-names></name> <name><surname>Tomar</surname> <given-names>D. S.</given-names></name> <name><surname>Karunakaran</surname> <given-names>S.</given-names></name> <name><surname>Bapat</surname> <given-names>D.</given-names></name> <name><surname>Nanguneri</surname> <given-names>S.</given-names></name> <name><surname>Ray</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Glutaredoxin1 diminishes amyloid Beta-mediated oxidation of F-actin and reverses cognitive deficits in an Alzheimer&#x2019;s disease mouse model</article-title>. <source>Antioxid. Redox Signal.</source> <volume>31</volume>, <fpage>1321</fpage>&#x2013;<lpage>1338</lpage>. doi: <pub-id pub-id-type="doi">10.1089/ars.2019.7754</pub-id>, PMID: <pub-id pub-id-type="pmid">31617375</pub-id></citation>
</ref>
<ref id="ref35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>S.</given-names></name> <name><surname>Frost</surname> <given-names>J. L.</given-names></name> <name><surname>Cotman</surname> <given-names>C. W.</given-names></name> <name><surname>Head</surname> <given-names>E.</given-names></name> <name><surname>Palmour</surname> <given-names>R.</given-names></name> <name><surname>Lemere</surname> <given-names>C. A.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Deposition of phosphorylated amyloid-&#x03B2; in brains of aged nonhuman primates and canines</article-title>. <source>Brain Pathol.</source> <volume>28</volume>, <fpage>427</fpage>&#x2013;<lpage>430</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bpa.12573</pub-id>, PMID: <pub-id pub-id-type="pmid">29740941</pub-id></citation>
</ref>
<ref id="ref36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kummer</surname> <given-names>M. P.</given-names></name> <name><surname>Heneka</surname> <given-names>M. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Truncated and modified amyloid-beta species</article-title>. <source>Alzheimers Res. Ther.</source> <volume>6</volume>:<fpage>28</fpage>. doi: <pub-id pub-id-type="doi">10.1186/alzrt258</pub-id>, PMID: <pub-id pub-id-type="pmid">25031638</pub-id></citation>
</ref>
<ref id="ref37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Louise</surname> <given-names>C.</given-names></name> <name><surname>Etienne</surname> <given-names>D.</given-names></name> <name><surname>Marie-Pierre</surname> <given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>AFM sensing cortical actin cytoskeleton destabilization during plasma membrane electropermeabilization</article-title>. <source>Cytoskeleton</source> <volume>71</volume>, <fpage>587</fpage>&#x2013;<lpage>594</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cm.21194</pub-id>, PMID: <pub-id pub-id-type="pmid">25308626</pub-id></citation>
</ref>
<ref id="ref38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Q.</given-names></name> <name><surname>Kuang</surname> <given-names>D.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Song</surname> <given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Cell stiffness determined by atomic force microscopy and its correlation with cell motility</article-title>. <source>Biochim. Biophys. Acta Gen. Subj.</source> <volume>1860</volume>, <fpage>1953</fpage>&#x2013;<lpage>1960</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbagen.2016.06.010</pub-id>, PMID: <pub-id pub-id-type="pmid">27288584</pub-id></citation>
</ref>
<ref id="ref39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mihai</surname> <given-names>C.</given-names></name> <name><surname>Bao</surname> <given-names>S.</given-names></name> <name><surname>Lai</surname> <given-names>J.-P.</given-names></name> <name><surname>Ghadiali</surname> <given-names>S. N.</given-names></name> <name><surname>Knoell</surname> <given-names>D. L.</given-names></name></person-group> (<year>2012</year>). <article-title>PTEN inhibition improves wound healing in lung epithelia through changes in cellular mechanics that enhance migration</article-title>. <source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source> <volume>302</volume>, <fpage>L287</fpage>&#x2013;<lpage>L299</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajplung.00037.2011</pub-id>, PMID: <pub-id pub-id-type="pmid">22037358</pub-id></citation>
</ref>
<ref id="ref40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minamide</surname> <given-names>L. S.</given-names></name> <name><surname>Striegl</surname> <given-names>A. M.</given-names></name> <name><surname>Boyle</surname> <given-names>J. A.</given-names></name> <name><surname>Meberg</surname> <given-names>P. J.</given-names></name> <name><surname>Bamburg</surname> <given-names>J. R.</given-names></name></person-group> (<year>2000</year>). <article-title>Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function</article-title>. <source>Nat. Cell Biol.</source> <volume>2</volume>, <fpage>628</fpage>&#x2013;<lpage>636</lpage>. doi: <pub-id pub-id-type="doi">10.1038/35023579</pub-id>, PMID: <pub-id pub-id-type="pmid">10980704</pub-id></citation>
</ref>
<ref id="ref41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitkevich</surname> <given-names>V. A.</given-names></name> <name><surname>Petrushanko</surname> <given-names>I. Y.</given-names></name> <name><surname>Yegorov</surname> <given-names>Y. E.</given-names></name> <name><surname>Simonenko</surname> <given-names>O. V.</given-names></name> <name><surname>Vishnyakova</surname> <given-names>K. S.</given-names></name> <name><surname>Kulikova</surname> <given-names>A. A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Isomerization of Asp7 leads to increased toxic effect of amyloid-beta42 on human neuronal cells</article-title>. <source>Cell Death Dis.</source> <volume>4</volume>:<fpage>e939</fpage>. doi: <pub-id pub-id-type="doi">10.1038/cddis.2013.492</pub-id>, PMID: <pub-id pub-id-type="pmid">24287700</pub-id></citation>
</ref>
<ref id="ref42">
<citation citation-type="journal"><person-group person-group-type="author">
<name><surname>Mizuno</surname> <given-names>K.</given-names></name>
</person-group> (<year>2013</year>). <article-title>Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation</article-title>. <source>Cell. Signal.</source> <volume>25</volume>, <fpage>457</fpage>&#x2013;<lpage>469</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cellsig.2012.11.001</pub-id>, PMID: <pub-id pub-id-type="pmid">23153585</pub-id></citation>
</ref>
<ref id="ref43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname> <given-names>S.</given-names></name> <name><surname>Perez</surname> <given-names>K. A.</given-names></name> <name><surname>Lago</surname> <given-names>L. C.</given-names></name> <name><surname>Klatt</surname> <given-names>S.</given-names></name> <name><surname>McLean</surname> <given-names>C. A.</given-names></name> <name><surname>Birchall</surname> <given-names>I. E.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Quantification of N-terminal amyloid-&#x03B2; isoforms reveals isomers are the most abundant form of the amyloid-&#x03B2; peptide in sporadic Alzheimer&#x2019;s disease</article-title>. <source>Brain Commun.</source> <volume>3</volume>:<fpage>fcab028</fpage>. doi: <pub-id pub-id-type="doi">10.1093/braincomms/fcab028</pub-id>, PMID: <pub-id pub-id-type="pmid">33928245</pub-id></citation>
</ref>
<ref id="ref44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nehls</surname> <given-names>S.</given-names></name> <name><surname>N&#x00F6;ding</surname> <given-names>H.</given-names></name> <name><surname>Karsch</surname> <given-names>S.</given-names></name> <name><surname>Ries</surname> <given-names>F.</given-names></name> <name><surname>Janshoff</surname> <given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Stiffness of MDCK II cells depends on Confluency and cell size</article-title>. <source>Biophys. J.</source> <volume>116</volume>, <fpage>2204</fpage>&#x2013;<lpage>2211</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bpj.2019.04.028</pub-id>, PMID: <pub-id pub-id-type="pmid">31126583</pub-id></citation>
</ref>
<ref id="ref45">
<citation citation-type="journal"><person-group person-group-type="author">
<name><surname>Ohashi</surname> <given-names>K.</given-names></name>
</person-group> (<year>2015</year>). <article-title>Roles of cofilin in development and its mechanisms of regulation</article-title>. <source>Develop. Growth Differ.</source> <volume>57</volume>, <fpage>275</fpage>&#x2013;<lpage>290</lpage>. doi: <pub-id pub-id-type="doi">10.1111/dgd.12213</pub-id></citation>
</ref>
<ref id="ref46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pavlov</surname> <given-names>D.</given-names></name> <name><surname>Muhlrad</surname> <given-names>A.</given-names></name> <name><surname>Cooper</surname> <given-names>J.</given-names></name> <name><surname>Wear</surname> <given-names>M.</given-names></name> <name><surname>Reisler</surname> <given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Actin filament severing by Cofilin</article-title>. <source>J. Mol. Biol.</source> <volume>365</volume>, <fpage>1350</fpage>&#x2013;<lpage>1358</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmb.2006.10.102</pub-id>, PMID: <pub-id pub-id-type="pmid">17134718</pub-id></citation>
</ref>
<ref id="ref47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelucchi</surname> <given-names>S.</given-names></name> <name><surname>Stringhi</surname> <given-names>R.</given-names></name> <name><surname>Marcello</surname> <given-names>E.</given-names></name></person-group> (<year>2020</year>). <article-title>Dendritic spines in Alzheimer&#x2019;s disease: how the actin cytoskeleton contributes to synaptic failure</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>:<fpage>908</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms21030908</pub-id></citation>
</ref>
<ref id="ref48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pogoda</surname> <given-names>K.</given-names></name> <name><surname>Jaczewska</surname> <given-names>J.</given-names></name> <name><surname>Wiltowska-Zuber</surname> <given-names>J.</given-names></name> <name><surname>Klymenko</surname> <given-names>O.</given-names></name> <name><surname>Zuber</surname> <given-names>K.</given-names></name> <name><surname>Fornal</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Depth-sensing analysis of cytoskeleton organization based on AFM data</article-title>. <source>Eur. Biophys. J.</source> <volume>41</volume>, <fpage>79</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00249-011-0761-9</pub-id></citation>
</ref>
<ref id="ref49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname> <given-names>J. R.</given-names></name> <name><surname>Pabijan</surname> <given-names>J.</given-names></name> <name><surname>Garcia</surname> <given-names>R.</given-names></name> <name><surname>Lekka</surname> <given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>The softening of human bladder cancer cells happens at an early stage of the malignancy process</article-title>. <source>Beilstein J. Nanotechnol.</source> <volume>5</volume>, <fpage>447</fpage>&#x2013;<lpage>457</lpage>. doi: <pub-id pub-id-type="doi">10.3762/bjnano.5.52</pub-id>, PMID: <pub-id pub-id-type="pmid">24778971</pub-id></citation>
</ref>
<ref id="ref50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roduit</surname> <given-names>C.</given-names></name> <name><surname>Sekatski</surname> <given-names>S.</given-names></name> <name><surname>Dietler</surname> <given-names>G.</given-names></name> <name><surname>Catsicas</surname> <given-names>S.</given-names></name> <name><surname>Lafont</surname> <given-names>F.</given-names></name> <name><surname>Kasas</surname> <given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Stiffness tomography by atomic force microscopy</article-title>. <source>Biophys. J.</source> <volume>97</volume>, <fpage>674</fpage>&#x2013;<lpage>677</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bpj.2009.05.010</pub-id>, PMID: <pub-id pub-id-type="pmid">19619482</pub-id></citation>
</ref>
<ref id="ref51">
<citation citation-type="journal"><person-group person-group-type="author">
<name><surname>Rust</surname> <given-names>M. B.</given-names></name>
</person-group> (<year>2015</year>). <article-title>ADF/cofilin: a crucial regulator of synapse physiology and behavior</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>72</volume>, <fpage>3521</fpage>&#x2013;<lpage>3529</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-015-1941-z</pub-id></citation>
</ref>
<ref id="ref52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarmiere</surname> <given-names>P. D.</given-names></name> <name><surname>Bamburg</surname> <given-names>J. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Regulation of the neuronal actin cytoskeleton by ADF/cofilin</article-title>. <source>J. Neurobiol.</source> <volume>58</volume>, <fpage>103</fpage>&#x2013;<lpage>117</lpage>. doi: <pub-id pub-id-type="doi">10.1002/neu.10267</pub-id></citation>
</ref>
<ref id="ref53">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Son</surname> <given-names>Y.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Chung</surname> <given-names>H.-T.</given-names></name> <name><surname>Pae</surname> <given-names>H.-O.</given-names></name></person-group> (<year>2013</year>). &#x201C;<article-title>Chapter two - reactive oxygen species in the activation of MAP kinases</article-title>&#x201D; in <source>Methods in enzymology</source>. eds. <person-group person-group-type="editor"><name><surname>Cadenas</surname> <given-names>E.</given-names></name> <name><surname>Packer</surname> <given-names>L.</given-names></name></person-group> (<publisher-loc>London</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>27</fpage>&#x2013;<lpage>48</lpage>.</citation>
</ref>
<ref id="ref54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stroka</surname> <given-names>K. M.</given-names></name> <name><surname>Aranda-Espinoza</surname> <given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Effects of morphology vs. cell-cell interactions on endothelial cell stiffness</article-title>. <source>Cell. Mol. Bioeng.</source> <volume>4</volume>, <fpage>9</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12195-010-0142-y</pub-id>, PMID: <pub-id pub-id-type="pmid">21359128</pub-id></citation>
</ref>
<ref id="ref55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname> <given-names>H.</given-names></name> <name><surname>Tanaka</surname> <given-names>H.</given-names></name> <name><surname>Yasuda</surname> <given-names>S.</given-names></name> <name><surname>Takemiya</surname> <given-names>T.</given-names></name> <name><surname>Yamagata</surname> <given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Transducing neuronal activity into dendritic spine morphology: new roles for p38 MAP kinase and N-cadherin</article-title>. <source>Neuroscientist</source> <volume>15</volume>, <fpage>90</fpage>&#x2013;<lpage>104</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1073858408324024</pub-id>, PMID: <pub-id pub-id-type="pmid">19218233</pub-id></citation>
</ref>
<ref id="ref56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taulet</surname> <given-names>N.</given-names></name> <name><surname>Delorme-Walker</surname> <given-names>V. D.</given-names></name> <name><surname>DerMardirossian</surname> <given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Reactive oxygen species regulate protrusion efficiency by controlling actin dynamics</article-title>. <source>PLoS One</source> <volume>7</volume>:<fpage>e41342</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0041342</pub-id>, PMID: <pub-id pub-id-type="pmid">22876286</pub-id></citation>
</ref>
<ref id="ref57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ungureanu</surname> <given-names>A.-A.</given-names></name> <name><surname>Benilova</surname> <given-names>I.</given-names></name> <name><surname>Krylychkina</surname> <given-names>O.</given-names></name> <name><surname>Braeken</surname> <given-names>D.</given-names></name> <name><surname>De Strooper</surname> <given-names>B.</given-names></name> <name><surname>Van Haesendonck</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Amyloid beta oligomers induce neuronal elasticity changes in age-dependent manner: a force spectroscopy study on living hippocampal neurons</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>25841</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep25841</pub-id>, PMID: <pub-id pub-id-type="pmid">27173984</pub-id></citation>
</ref>
<ref id="ref58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaneev</surname> <given-names>A. N.</given-names></name> <name><surname>Gorelkin</surname> <given-names>P. V.</given-names></name> <name><surname>Garanina</surname> <given-names>A. S.</given-names></name> <name><surname>Lopatukhina</surname> <given-names>H. V.</given-names></name> <name><surname>Vodopyanov</surname> <given-names>S. S.</given-names></name> <name><surname>Alova</surname> <given-names>A. V.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>In vitro and in vivo electrochemical measurement of reactive oxygen species after treatment with anticancer drugs</article-title>. <source>Anal. Chem.</source> <volume>92</volume>, <fpage>8010</fpage>&#x2013;<lpage>8014</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.analchem.0c01256</pub-id>, PMID: <pub-id pub-id-type="pmid">32441506</pub-id></citation>
</ref>
<ref id="ref59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Boja</surname> <given-names>E. S.</given-names></name> <name><surname>Tan</surname> <given-names>W.</given-names></name> <name><surname>Tekle</surname> <given-names>E.</given-names></name> <name><surname>Fales</surname> <given-names>H. M.</given-names></name> <name><surname>English</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Reversible Glutathionylation regulates actin polymerization in A431 cells &#x002A;</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>47763</fpage>&#x2013;<lpage>47766</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.C100415200</pub-id>, PMID: <pub-id pub-id-type="pmid">11684673</pub-id></citation>
</ref>
<ref id="ref60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Ma</surname> <given-names>J.</given-names></name> <name><surname>Tan</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Sheng</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Amyloid-beta1-42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells</article-title>. <source>J. Alzheimers Dis.</source> <volume>21</volume>, <fpage>597</fpage>&#x2013;<lpage>610</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-2010-091207</pub-id>, PMID: <pub-id pub-id-type="pmid">20571221</pub-id></citation>
</ref>
<ref id="ref61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Q.</given-names></name> <name><surname>Yuan</surname> <given-names>W.</given-names></name> <name><surname>Yang</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Qiao</surname> <given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Role of Cofilin in Alzheimer&#x2019;s disease</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>8</volume>. doi: <pub-id pub-id-type="doi">10.3389/fcell.2020.584898</pub-id>, PMID: <pub-id pub-id-type="pmid">33324642</pub-id></citation>
</ref>
<ref id="ref62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Vikash</surname> <given-names>V.</given-names></name> <name><surname>Ye</surname> <given-names>Q.</given-names></name> <name><surname>Wu</surname> <given-names>D.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>ROS and ROS-mediated cellular signaling</article-title>. <source>Oxidative Med. Cell. Longev.</source> <volume>2016</volume>:<fpage>4350965</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2016/4350965</pub-id>, PMID: <pub-id pub-id-type="pmid">26998193</pub-id></citation>
</ref>
</ref-list>
</back>
</article>